The stock has a 36-month beta value of 0.65. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ANGO is 38.64M, and at present, short sellers hold a 2.92% of that float. On October 23, 2024, the average trading volume of ANGO was 493.80K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ANGO) stock’s latest price update
Angiodynamic Inc (NASDAQ: ANGO)’s stock price has gone rise by 11.16 in comparison to its previous close of 6.54, however, the company has experienced a 14.85% increase in its stock price over the last five trading days. zacks.com reported 2024-10-08 that AngioDynamics (ANGO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANGO’s Market Performance
ANGO’s stock has risen by 14.85% in the past week, with a monthly drop of -3.07% and a quarterly drop of -0.82%. The volatility ratio for the week is 5.50% while the volatility levels for the last 30 days are 5.28% for Angiodynamic Inc. The simple moving average for the past 20 days is 8.31% for ANGO’s stock, with a 12.93% simple moving average for the past 200 days.
Analysts’ Opinion of ANGO
Many brokerage firms have already submitted their reports for ANGO stocks, with Oppenheimer repeating the rating for ANGO by listing it as a “Outperform.” The predicted price for ANGO in the upcoming period, according to Oppenheimer is $12 based on the research report published on April 05, 2024 of the current year 2024.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see ANGO reach a price target of $19. The rating they have provided for ANGO stocks is “Buy” according to the report published on September 25th, 2023.
Raymond James gave a rating of “Outperform” to ANGO, setting the target price at $13 in the report published on April 17th of the previous year.
ANGO Trading at 1.33% from the 50-Day Moving Average
After a stumble in the market that brought ANGO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.88% of loss for the given period.
Volatility was left at 5.28%, however, over the last 30 days, the volatility rate increased by 5.50%, as shares sank -4.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.28% lower at present.
During the last 5 trading sessions, ANGO rose by +14.85%, which changed the moving average for the period of 200-days by +17.07% in comparison to the 20-day moving average, which settled at $6.71. In addition, Angiodynamic Inc saw -7.27% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ANGO starting from Nighan Warren JR, who purchase 768 shares at the price of $6.09 back on Oct 07 ’24. After this action, Nighan Warren JR now owns 45,777 shares of Angiodynamic Inc, valued at $4,677 using the latest closing price.
Nighan Warren JR, the SVP Quality and Regulatory of Angiodynamic Inc, purchase 100 shares at $6.08 during a trade that took place back on Oct 10 ’24, which means that Nighan Warren JR is holding 45,877 shares at $608 based on the most recent closing price.
Stock Fundamentals for ANGO
Current profitability levels for the company are sitting at:
- -0.15 for the present operating margin
- 0.5 for the gross margin
The net margin for Angiodynamic Inc stands at -0.83. The total capital return value is set at -0.2. Equity return is now at value -77.85, with -61.72 for asset returns.
Based on Angiodynamic Inc (ANGO), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -4.27. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -29.18.
Currently, EBITDA for the company is -6.1 million with net debt to EBITDA at -8.69. When we switch over and look at the enterprise to sales, we see a ratio of 0.84. The receivables turnover for the company is 7.4for trailing twelve months and the total asset turnover is 1.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.25.
Conclusion
To sum up, Angiodynamic Inc (ANGO) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
